住院期间阿片类药物使用是否影响全关节置换术后的阿片类药物消耗
该研究回顾性分析了369例在学术中心接受初次全关节置换术的患者,通过州药物监测数据库获取术前90天和术后90天阿片类药物处方,并收集术前单元、手术室、麻醉后监护室和病房的住院期间阿片类药物消耗数据。多变量分析显示,住院期间阿片类药物总消耗量与术后阿片类药物使用独立相关(rs=0.17,P=0.0010),术前阿片类药物消耗量是术后过度使用的最强风险因素(rs=0.44,P<.0001)。
要点
- 住院期间阿片类药物总消耗量与术后阿片类药物使用独立相关(rs=0.17,P=0.0010)。
- 术前阿片类药物消耗量是术后过度使用的最强风险因素(rs=0.44,P<.0001)。
- 病房阿片类药物消耗与术前单元(rs=0.11,P=0.0338)和麻醉后监护室(rs=0.15,P=0.0032)消耗相关。
核心结论
- 住院期间阿片类药物使用与术前和术后阿片类药物消耗独立相关。
- 术前阿片类药物使用仍是全关节置换术后阿片类药物消耗增加的最大风险因素。
- 多模式方法减少住院期间对阿片类药物的依赖可能有助于进一步减少术后使用。
研究设计与样本
- 回顾性综述了在学术中心9个月期间连续369例接受初次全关节置换术的患者。
- 从州药物监测数据库获取术前90天和术后90天阿片类药物处方。
- 从术前单元、手术室、麻醉后监护室和病房获取住院期间阿片类药物消耗数据。
- 采用多变量分析比较患者住院期间阿片类药物总消耗量与术前和术后使用。
主要发现
- 住院期间阿片类药物总消耗量与术后阿片类药物使用独立相关(rs=0.17,P=0.0010)。
- 病房阿片类药物消耗与术前单元阿片类药物使用相关(rs=0.11,P=0.0338)。
- 病房阿片类药物消耗与麻醉后监护室阿片类药物使用相关(rs=0.15,P=0.0032)。
- 术前阿片类药物消耗增加是术后过度使用的最强风险因素(rs=0.44,P<.0001)。
- 年龄<65岁的患者中高术后阿片类药物消耗者比例更大(P=0.0146),且全膝关节置换术患者在高使用组中显著更多(P=0.0006)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative opioid use strongly correlates with greater postoperative opioid use and complications following total joint arthroplasty (TJA). However, there is a lack of information regarding the effect of opioid consumption during the hospital stay and within the operating room on postoperative opioid use. METHODS: We retrospectively reviewed 369 consecutive patients undergoing primary TJA at an academic center over a 9-month period. Ninety-day preoperative and postoperative opioid prescriptions were obtained from the state's drug monitoring database. In-hospital opioid consumption data was obtained from the preoperative unit, operating room, postanesthesia care unit (PACU), and hospital floor. Multivariate analysis was utilized to compare patients' total in-hospital opioid consumption with their preoperative and postoperative use, along with opioid use throughout the hospitalization. RESULTS: Total in-hospital opioid consumption was independently associated with postoperative opioid use (rs = 0.17, P = .0010). Opioids consumed on the hospital floor correlated with opioid use in the preoperative unit (rs = 0.11, P = .0338) and PACU (rs = 0.15, P = .0032). Increased preoperative opioid consumption was the greatest risk factor for excessive postoperative use (rs = 0.44, P < .0001). A greater proportion of patients <65 years of age were high posthospital opioid consumers (P = .0146) and significantly more TKA patients were in the higher use groups (P = .0006). CONCLUSION: In-hospital opioid use is independently associated with preoperative and postoperative consumption. Preoperative opioid use remains the greatest risk factor for increased opioid consumption after TJA. Multimodal approaches to decrease reliance on opioids for pain control during hospitalization may offer hope to further decrease postoperative usage. LEVEL OF EVIDENCE: III.
引用
- O'Brien PE, Mears SC, Siegel ER, et al. Does In-Hospital Opioid Use Affect Opioid Consumption After Total Joint Arthroplasty? J Arthroplasty. 2022. PMID: 35114319. doi:10.1016/j.arth.2022.01.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。